Parkinson’s: New treatment may help reduce motor symptoms
Prasinezumab, an experimental monoclonal antibody treatment, may help reduce the deterioration of motor skills in people with rapidly progressing Parkinson’s disease, a new study suggests.
Prasinezumab, an experimental monoclonal antibody treatment, may help reduce the deterioration of motor skills in people with rapidly progressing Parkinson’s disease, a new study suggests.
A Cell Press collection on immunology showcasing leading research and reviews from across our portfolio.
A torc, valued at £220,000 when it was bought, is one of two items dating from 3,000 years ago.
In a new study, Oregon Health & Science University researchers report that combined cannabis and nicotine use during pregnancy is associated with significantly higher risk…
The role of artificial intelligence (AI) in healthcare and medicine is rapidly evolving. In this TEDMED Conversation, Bapu Jena, MD, PhD, Physician, Economis…
Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss its experimental Alzheimer’s disease drug, donanemab, on June 10.
Discover how Mass General Brigham’s Home Hospital Emergency Care program is revolutionizing emergency and urgent care by treating patients at home.
200 days into Israel’s military bombardment and siege of Gaza, we are witnessing the onset of a man made and entirely preventable famine, say Sameer…
Acute kidney injury (AKI) often complicates sepsis and is associated with high morbidity and mortality. In recent years, several important clinical trials have improved our…
Researchers say people who consume a half tablespoon of olive oil per day have a lower risk of dementia-related death. The study is in line…
America’s opioid crisis spiked during the COVID-19 pandemic. Economic disruption, social isolation, and despair all helped drive fatal overdoses to one record number after another…